Home > Insider Trading > Filing (0001441372-10-000004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1496268	Reva Medical Inc.	RVA	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	330810505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1441372	Saints Capital Everest Lp	475 Sansome Street Suite 1850 San Francisco CA 94111		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-12-16	1,204,180	$0.00	1,204,180	No	4	C	Direct
Common Stock	Acquisiton	2010-12-16	102,883	$0.00	1,307,063	No	4	C	Direct
Common Stock	Acquisiton	2010-12-16	17,147	$6.51	1,324,210	No	4	X	Direct
Common Stock	Disposition	2010-12-16	10,185	$10.95	1,314,025	No	4	F	Direct
Common Stock	Acquisiton	2010-12-16	3,430	$6.51	1,317,455	No	4	X	Direct
Common Stock	Disposition	2010-12-16	2,037	$10.95	1,315,418	No	4	F	Direct
Common Stock	Acquisiton	2010-12-16	3,158,164	$6.51	4,473,582	No	4	C	Direct
Common Stock	Acquisiton	2010-12-16	90,909	$1.10	4,564,491	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	F	Direct
No	4	X	Direct
No	4	F	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series G-1 Preferred Stock	Disposition	2010-12-16	1,204,180	$0.00	1,204,180	$0.00
Common Stock	Series H Preferred Stock	Disposition	2010-12-16	102,883	$0.00	102,883	$0.00
Common Stock	Warrant (right to buy)	Disposition	2010-12-16	17,147	$0.00	17,147	$6.51
Common Stock	Warrant (right to buy)	Disposition	2010-12-16	3,430	$0.00	3,430	$6.51
Common Stock	Convertible Note	Disposition	2010-12-16	3,146,911	$0.00	3,146,911	$6.51

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
		No	4	C	Direct
		No	4	C	Direct
2010-05-25	2012-12-07	No	4	X	Direct
2010-06-02	2012-12-07	No	4	X	Direct
2005-06-08	2011-12-31	No	4	C	Direct

Footnotes

Each share of Series G-1 Preferred Stock was automatically converted into 1.187321 shares of Common Stock upon closing of the Issuer's initial public offering.
Each share of Series H Preferred Stock was automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
The Series G-1 and H Preferred Stock have no expiration date.
Reflects the cashless exercise of the warrant, resulting in the issuance to the Reporting Person of 6,962 shares of common stock and cancellation of the warrant with respect to the balance of 10,185 shares of common stock.
Reflects the cashless exercise of the warrant, resulting in the issuance to the Reporting Person of 1,393 shares of common stock and cancellation of the warrant with respect to the balance of 2,037 shares of common stock.
The outstanding principal and accrued and unpaid interest on these convertible promissory notes automatically converted into shares of common stock upon the closing of the Issuer's initial public offering, at $6.5066 per share.
Represents the U.S. dollar price paid for 90,909 shares of common stock purchased on the Australian Stock Exchange in the form of Chess Depositary Interests ("CDIs") on December 16, 2010. The purchaser price per CDI of $1.10 was calculated using the Aus.$/U.S.$ exchange rate on December 7, 2010 of 0.9983.